NEOGAP Therapeutics Revenue

Pharmaceutical Manufacturing • Visionsgatan 56, Cancer Center Karolinska, Sweden • 21-50 Employees

NEOGAP Therapeutics revenue & valuation

Annual revenue	$2,395,540
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$7,700,000
Total funding	$5,372,200

Key Contact at NEOGAP Therapeutics

Samuel Svensson

Ceo

Company overview

Headquarters	Visionsgatan 56, Cancer Center Karolinska, Stockholm, 17164, SE
Phone number	+46733542194
Website	neogap.se
NAICS	3254
Keywords	Immunotherapy, Immuno-Oncology, Biopharmaceutical Company
Founded	2016
Employees	21-50
Socials

NEOGAP Therapeutics Email Formats

NEOGAP Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@neogap.se), used 76.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@neogap.se	76.9%
{first initial}.{last name}	j.doe@neogap.se	23.1%

About NEOGAP Therapeutics

NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Manager

Employees by Department

NEOGAP Therapeutics has 10 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore NEOGAP Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-12-09	1	$4,900,000
2024-04-26	9	$472,200

Funding Insights

$5,372,200

Total funding amount

$472,200

Most recent funding amount

Number of funding rounds

NEOGAP Therapeutics Tech Stack

Discover the technologies and tools that power NEOGAP Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Underscore.js

JavaScript libraries

Vimeo

Video players

PubSubJS

JavaScript libraries

jQuery UI

JavaScript libraries

Animate.css

UI frameworks

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

Frequently asked questions

NEOGAP Therapeutics is located in Visionsgatan 56, Cancer Center Karolinska, SE.

You can reach NEOGAP Therapeutics at +46733542194.

NEOGAP Therapeutics generates an estimated annual revenue of $2,395,540. This revenue figure reflects the company's market position and business performance in its industry.

NEOGAP Therapeutics has an estimated valuation of $7,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NEOGAP Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

NEOGAP Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

NEOGAP Therapeutics has raised a total of $5,372,200 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at NEOGAP Therapeutics

Samuel Svensson

Ceo

4.8

40,000 users